Anti-human CXCR4 antibodies and methods of making same
US9260527B2 · kind B2 · utility
1Cited by
84References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 2014 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Mar 18, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides novel antibodies to human CXCR4 with high affinity to the target and the ability to act potently as antagonists. The antibodies disclosed herein bind to a diverse range of epitopes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.